| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | FI | PI | | Antihydral | 25 g | PA | PA | k.A. | | Salbe: Methenaminum 130 mg | steinberg pharma ag | D / LPPV | FB | | G |  |
| | FI | PI | | Sansudor | 60 ml | 5.92 | 10.90 | k.A. | | Crème: Dialuminii Chloridum Pentahydroxidum 190 mg | Boehringer Ingelheim (Schweiz) GmbH | D | FB | | G |  |
|
L | | FI | PI | | Alitretinoin Leman 10 mg | 30 | 165.00 | 199.65 | 10% | | Weichkapseln: Alitretinoinum 10 mg | Leman SKL SA | A / SL / SG | FB | | G |  |
L | | FI | | | Alitretinoin Leman 30 mg | 30 | 165.00 | 199.65 | 10% | | Weichkapseln: Alitretinoinum 30 mg | Leman SKL SA | A / SL / SG | FB | | G |  |
L | | FI | PI | | Toctino 10 mg | 30 Kapsel(n) | 219.00 | 255.05 | 10% | | Weichkapseln: Alitretinoinum 10 mg | GlaxoSmithKline AG | A / SL / SO | FB | | G |  |
L | | FI | PI | | Toctino 30 mg | 30 Kapsel(n) | 219.00 | 255.05 | 10% | | Weichkapseln: Alitretinoinum 30 mg | GlaxoSmithKline AG | A / SL / SO | FB | | G |  |
L | | FI | PI | | Alitrecutan 10 mg | 30 | 215.00 | 250.95 | 10% | | Weichkapseln: Alitretinoinum 10 mg | Dermapharm AG | A / SL / SG | FB | | G |  |
L | | FI | | | Alitrecutan 30 mg | 30 | 215.00 | 250.95 | 10% | | Weichkapseln: Alitretinoinum 30 mg | Dermapharm AG | A / SL / SG | FB | | G |  |
|
L | | FI | | | Dupixent 300 mg/ 2 ml | 2 x 2 ml | 1065.68 | 1175.40 | 10% | | solution injectable en stylo pré-rempli: Dupilumabum 300mg / 2ml | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G |  |
L | | FI | PI | | Dupixent 200 mg/ 1.14 ml | 2 x 1.14 ml | 1065.68 | 1175.40 | 10% | | solution injectable en stylo pré-rempli: Dupilumabum 200mg / 1.14ml | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G |  |
L | | FI | PI | | Dupixent 300 mg/2 ml | 2 | 1065.68 | 1175.40 | 10% | | solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 300mg / 2ml | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G |  |
L | | FI | PI | | Dupixent 200 mg/1.14 ml | 2 | 1065.68 | 1175.40 | 10% | | solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 200mg / 1.14ml | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G |  |
| | FI | PI | | Dupixent 300 mg/ 2 ml | 2 x 2 ml | 1065.68 | 1175.40 | k.A. | | solution injectable en stylo pré-rempli: Dupilumabum 300mg / 2ml | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Dupixent 200 mg/ 1.14 ml | 2 x 1.14 ml | 1065.68 | 1175.40 | k.A. | | solution injectable en stylo pré-rempli: Dupilumabum 200mg / 1.14ml | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
|
L | | FI | PI | | Cibinqo 50 mg | 28 | 937.81 | 1036.35 | 10% | | Filmtabletten: Abrocitinibum 50 mg | Pfizer AG | B / SL | FB | | G |  |
L | | FI | | | Cibinqo 100 mg | 28 | 937.81 | 1036.35 | 10% | | Filmtabletten: Abrocitinibum 100 mg | Pfizer AG | B / SL | FB | | G |  |
| | FI | PI | | Cibinqo 50 mg | 14 | PA | PA | k.A. | | Filmtabletten: Abrocitinibum 50 mg | Pfizer AG | B | FB | | G |  |
| | FI | PI | | Cibinqo 50 mg | 91 | PA | PA | k.A. | | Filmtabletten: Abrocitinibum 50 mg | Pfizer AG | B | FB | | G |  |
| | FI | | | Cibinqo 100 mg | 14 | PA | PA | k.A. | | Filmtabletten: Abrocitinibum 100 mg | Pfizer AG | B | FB | | G |  |
| | FI | | | Cibinqo 100 mg | 91 | PA | PA | k.A. | | Filmtabletten: Abrocitinibum 100 mg | Pfizer AG | B | FB | | G |  |
|
| | | PI | | Linola | 50 g | PA | PA | k.A. | | Emulsion: Acida Oligoinsaturata 5 mg/g | Alcina AG | D | FB | | G |  |
| | | PI | | Linola | 150 g | PA | PA | k.A. | | Emulsion: Acida Oligoinsaturata 5 mg/g | Alcina AG | D | FB | | G |  |
| | | PI | | Linola Fett | 50 g | PA | PA | k.A. | | Emulsion: Acida Oligoinsaturata 8.15 mg/g | Alcina AG | D | FB | | G |  |
| | | PI | | Linola Fett | 150 g | PA | PA | k.A. | | Emulsion: Acida Oligoinsaturata 8.15 mg/g | Alcina AG | D | FB | | G |  |
| | FI | PI | Ph | Kamillex | 100 ml | 3.60 | 6.65 | 10% | | | Streuli Pharma AG | D / SL | FB | | G |  |
| | FI | PI | Ph | Kamillex | 200 ml | 6.35 | 11.75 | 10% | | | Streuli Pharma AG | D / SL | FB | | G |  |
L | | | PI | | Linola | 40 g | 3.40 | 6.30 | 10% | | Emulsion: Acida Oligoinsaturata 5 mg/g | Alcina AG | D / SL | FB | | G |  |
L | | | PI | | Linola | 100 g | 7.02 | 12.95 | 10% | | Emulsion: Acida Oligoinsaturata 5 mg/g | Alcina AG | D / SL | FB | | G |  |
L | | | PI | | Linola Fett | 40 g | 3.40 | 6.30 | 10% | | Emulsion: Acida Oligoinsaturata 8.15 mg/g | Alcina AG | D / SL | FB | | G |  |
L | | | PI | | Linola Fett | 100 g | 7.02 | 12.95 | 10% | | Emulsion: Acida Oligoinsaturata 8.15 mg/g | Alcina AG | D / SL | FB | | G |  |
| | FI | PI | Ph | Kamillex | 500 ml | PA | 19.30 | k.A. | | | Streuli Pharma AG | D | FB | | G |  |
| | | PI | | Pantogar | 90 Kapsel(n) | PA | 56.85 | k.A. | | Kapseln: 6 Wirkstoffe | Merz Pharma (Schweiz) AG | D / LPPV | FB | | G |  |
| | | PI | | Pantogar | 300 Kapsel(n) | PA | 146.65 | k.A. | | Kapseln: 6 Wirkstoffe | Merz Pharma (Schweiz) AG | D / LPPV | FB | | G |  |
| | | PI | | Priorin N | 90 Kapsel(n) | PA | PA | k.A. | | Kapseln: 4 Wirkstoffe | Bayer (Schweiz) AG | D | FB | | G |  |
| | | PI | | Priorin N | 90 Kapsel(n) | PA | PA | k.A. | | Kapseln: 4 Wirkstoffe | Bayer (Schweiz) AG | D / LPPV | FB | | G |  |
| | | PI | | Priorin N | 180 Kapsel(n) | PA | 97.30 | k.A. | | Kapseln: 4 Wirkstoffe | Bayer (Schweiz) AG | D | FB | | G |  |
| | | PI | | Priorin N | 180 Kapsel(n) | PA | PA | k.A. | | Kapseln: 4 Wirkstoffe | Bayer (Schweiz) AG | D / LPPV | FB | | G |  |
| | | PI | | Priorin N | 270 Kapsel(n) | PA | PA | k.A. | | Kapseln: 4 Wirkstoffe | Bayer (Schweiz) AG | D | FB | | G |  |
| | | PI | | Priorin N | 270 Kapsel(n) | PA | PA | k.A. | | Kapseln: 4 Wirkstoffe | Bayer (Schweiz) AG | D / LPPV | FB | | G |  |
| | FI | PI | | Tannosynt flüssig | 100 g | 4.44 | 8.20 | k.A. | | Konzentrat zur Herstellung einer Lösung zur Anwendung auf der Haut: Phenoli/phenoli Sulfonatis/formaldehydi/urei Condensatum Natricum 400 mg/g | Almirall AG | D | FB | | G |  |
| | | | | Moorschwebstoffbad Schwanberg | 7 Portionenbeutel à 250 g | PA | PA | k.A. | | Badeessenz: Terra Uliginosa "schwanberg" | Kurz Hermann | D | FB | | G |  |
| | FI | | | Medizinisches Badesalz aus dem Toten Meer | 1.5 kg | PA | PA | k.A. | | Badesalz: 8 Wirkstoffe | Parsenn-Produkte AG | D | FB | | G |  |
| | FI | | | Medizinisches Badesalz aus dem Toten Meer | 3 x 1.5 kg | PA | PA | k.A. | | Badesalz: 8 Wirkstoffe | Parsenn-Produkte AG | D | FB | | G |  |
| | FI | | | Medizinisches Badesalz aus dem Toten Meer | 10 kg | PA | PA | k.A. | | Badesalz: 8 Wirkstoffe | Parsenn-Produkte AG | D | FB | | G |  |
| | | | | Phlogidermil | 50 g | PA | PA | k.A. | | Salbe: 6 Wirkstoffe | Corden Pharma Fribourg SA | D | FB | | G |  |
| | | | | Phlogidermil | 90 g | PA | PA | k.A. | | Salbe: 6 Wirkstoffe | Corden Pharma Fribourg SA | D | FB | | G |  |
| | | PI | | Topaceta | 50 g | PA | PA | k.A. | | Salbe: 3 Wirkstoffe | G. Streuli & Co. AG | D | FB | | G |  |
| | | PI | | Topaceta | 100 g | PA | PA | k.A. | | Salbe: 3 Wirkstoffe | G. Streuli & Co. AG | D | FB | | G |  |
| | | | | Tannolact Lotio | 75 g | PA | PA | k.A. | | | Galderma SA | C | FB | | G |  |
| | FI | PI | | Tannosynt | 100 g | PA | PA | k.A. | | Lotion: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | C | FB | | G |  |
| | | | | Homosan | 180 Dragée(s) | PA | PA | k.A. | | Dragées: Keratinum Hydrolysatum 250 mg | Sanfarm SA | D | FB | | G |  |
| | FI | PI | | Gelacet | 189 Kapsel(n) | PA | PA | k.A. | | Kapseln: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | | | | Mavala | 5 ml | PA | PA | k.A. | | Lösung: 3 Wirkstoffe | Mavala SA | E | FB | | G |  |
| | | | | Trind Nail-Repair brillant | 11 ml | PA | PA | k.A. | | Lösung: 2 Wirkstoffe | PHP Distribution Sélective SA | E | FB | | G |  |
| | | | | Trind Nail-Repair mat | 11 ml | PA | PA | k.A. | | Lösung: 2 Wirkstoffe | PHP Distribution Sélective SA | E | FB | | G |  |
|
| | FI | PI | | Regaine 5% | 3 x 60 g | PA | PA | k.A. | | Schaum zur Anwendung auf der Haut: Minoxidilum 50 mg/g | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Minoxidil Leman 20 mg/ml | 60 ml | PA | PA | k.A. | | solution pour application cutanée: Minoxidilum 20 mg/ml | Leman SKL SA | D | FB | | G |  |
| | FI | PI | | Minoxidil Leman 20 mg/ml | 3 x 60 ml | PA | PA | k.A. | | solution pour application cutanée: Minoxidilum 20 mg/ml | Leman SKL SA | D | FB | | G |  |
| | FI | PI | | Minoxidil Leman 50 mg/ml | 60 ml | PA | PA | k.A. | | solution pour application cutanée: Minoxidilum 50 mg/ml | Leman SKL SA | D | FB | | G |  |
| | FI | PI | | Minoxidil Leman 50 mg/ml | 3 x 60 ml | PA | PA | k.A. | | solution pour application cutanée: Minoxidilum 50 mg/ml | Leman SKL SA | D | FB | | G |  |
| | FI | PI | | Alopexy 2% | 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg/ml | Pierre Fabre Pharma SA | D / LPPV | FB | | G |  |
| | FI | PI | | Alopexy 2% | 3 x 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg/ml | Pierre Fabre Pharma SA | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 2 % | 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 2 % | 3 x 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 5 % | 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Regaine 5 % | 3 x 60 ml | PA | PA | k.A. | | Lösung: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Alopexy 5% | 60 ml | PA | PA | k.A. | | Lösung zur Anwendung auf der Haut: Minoxidilum | Pierre Fabre Pharma SA | D | FB | | G |  |
| | FI | PI | | Alopexy 5% | 3 x 60 ml | PA | PA | k.A. | | Lösung zur Anwendung auf der Haut: Minoxidilum | Pierre Fabre Pharma SA | D | FB | | G |  |
| | FI | PI | | Minorga 5% | 60 ml | PA | PA | k.A. | | solution pour aplication cutanée: Minoxidilum 50 mg/ml | Bailleul (Suisse) SA | D | FB | | G |  |
| | FI | PI | | Minorga 5% | 3 x 60 ml | PA | PA | k.A. | | solution pour aplication cutanée: Minoxidilum 50 mg/ml | Bailleul (Suisse) SA | D | FB | | G |  |
| | FI | PI | | Minorga 2 % | 60 ml | PA | PA | k.A. | | solution pour application cutanée: Minoxidilum 20 mg/ml | Bailleul (Suisse) SA | D | FB | | G |  |
| | FI | PI | | Minorga 2 % | 3 x 60 ml | PA | PA | k.A. | | solution pour application cutanée: Minoxidilum 20 mg/ml | Bailleul (Suisse) SA | D | FB | | G |  |
| | FI | PI | | Piloxil | 50 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg | Laboratoire Golaz SA | C | FB | | G |  |
| | FI | PI | | Piloxil | 50 ml | PA | PA | k.A. | | Lösung: Minoxidilum 20 mg | Laboratoire Golaz SA | C | FB | | G |  |
|
| | FI | PI | Ph | Epogam 1000 | 120 | 41.80 | 77.20 | 10% | | Kapseln: Oenotherae Seminis Oleum 1000 mg | Zeller Medical AG | D / SL | FB | | G |  |
| | FI | PI | Ph | Epogam 1000 | 240 | 73.48 | 135.70 | 10% | | Kapseln: Oenotherae Seminis Oleum 1000 mg | Zeller Medical AG | D / SL | FB | | G |  |
|
| | FI | PI | | Calciumgluconat 2.5% AApot | Flasche(n) | PA | PA | k.A. | | Hydrogel: Calcii Gluconas 25 mg | Armeeapotheke | B | FB | | G |  |
| | FI | PI | | Calciumgluconat 2.5% AApot | | PA | PA | k.A. | | Hydrogel: Calcii Gluconas 25 mg | Armeeapotheke | D | FB | | G |  |
|
| | FI | PI | | Fynzur 2,275 mg/ml | 18 ml | PA | PA | k.A. | | solution pour pulvérisation cutanée: Finasteridum 114 µg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Fynzur 2,275 mg/ml | 3 x 18 ml | PA | PA | k.A. | | solution pour pulvérisation cutanée: Finasteridum 114 µg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Andropecia Biorga 1 mg | 7 | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Andropecia Biorga 1 mg | 28 | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Andropecia Biorga 1 mg | 30 | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Andropecia Biorga 1 mg | 84 | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Andropecia Biorga 1 mg | 98 | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Bailleul (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Finacapil | 28 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Sandoz Pharmaceuticals AG | B / LPPV | FB | | G |  |
| | FI | PI | | Finacapil | 98 Tablette(n) | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Sandoz Pharmaceuticals AG | B / LPPV | FB | | G |  |
| | FI | PI | | Propecia | 84 | PA | PA | k.A. | | Filmtabletten: Finasteridum 1 mg | Organon GmbH | B | FB | | G |  |
| | FI | PI | | Finasterid-Mepha Procapil | 28 Tablette(n) | PA | PA | k.A. | | Filmtablette: Finasteridum 1 mg | Mepha Pharma AG | B / LPPV | FB | | G |  |
| | FI | PI | | Finasterid-Mepha Procapil | 98 Tablette(n) | PA | PA | k.A. | | Filmtablette: Finasteridum 1 mg | Mepha Pharma AG | B / LPPV | FB | | G |  |
|
| | FI | PI | | Pigmanorm | 30 g | 9.51 | 26.75 | 10% | | Crème: 3 Wirkstoffe | Louis Widmer AG | B / SL | FB | | G |  |
|
| | FI | PI | | Vaniqa | 30 g | PA | PA | k.A. | | Crème: Eflornithinum 115 mg | Almirall AG | B | FB | | G |  |
| | FI | PI | | Vaniqa | 60 g | PA | 148.65 | k.A. | | Crème: Eflornithinum 115 mg | Almirall AG | B / LPPV | FB | | G |  |
|
| | FI | PI | | Solaraze 3% | 25 g | 15.62 | 33.25 | 10% | | Gel: Diclofenacum Natricum 30 mg | Almirall AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Solaraze 3% | 50 g | 27.48 | 46.05 | 10% | | Gel: Diclofenacum Natricum 30 mg | Almirall AG | B / SL / SO | FB | | G |  |
| | FI | PI | | Solacutan 3% | 25 g | 13.27 | 30.85 | 10% | | Gel: Diclofenacum Natricum 30 mg | Dermapharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Solacutan 3% | 50 g | 23.36 | 41.80 | 10% | | Gel: Diclofenacum Natricum 30 mg | Dermapharm AG | B / SL / SG | FB | | G |  |
| | FI | PI | | Solacutan 3% | 100 g | PA | PA | k.A. | | Gel: Diclofenacum Natricum 30 mg | Dermapharm AG | B | FB | | G |  |
| | FI | PI | | Solaraze 3% | 100 g | PA | PA | k.A. | | Gel: Diclofenacum Natricum 30 mg | Almirall AG | B | FB | | G |  |
|
L | | FI | PI | PS | Mirvaso 3.3mg/g | 30 g | 37.44 | 57.15 | 10% | | Gel: Brimonidinum 3.3 mg | Galderma SA | B / SL | FB | | G |  |
|
| | FI | PI | PS | Soolantra 10 mg | 30 g | 16.37 | 34.20 | 10% | | Crème: Ivermectinum 10 mg | Galderma SA | B / SL | FB | | G |  |